Furthermore, in the TCGA CRC cohort, SLC2A1 expression level was remarkably positively associated with ALKBH5, FTO, IGF2BP1, IGF2BP2, METTL3, and RBM15B (p < 0.05) but negatively associated with METTL14, RBM15, and YTHDC2 (p < 0.05). The gene discussed is SLC2A1; the disease is colorectal carcinoma.